I saw some of those categories a couple of months ago, and -- as you might expect from. such a high approval rate -- there was little variance. The issues with CNS centered on efficacy.
The CNS category may have been ~ 82 percent, but the n there gets pretty small and 82 is not really different from 85 for statistical purposes.